Phase IV and RWE Services
“As your CRO and scientific service provider, OXON will plan and generate the highest quality Real-World data for Safety, Market access and Drug development.”
Our experts can help guide you through all available approaches, designs and implementation options for international field, database, and hybrid Real World Evidence studies to meet your needs in the most cost-efficient way.
OXON’s close links with centres of excellence at the London School of Hygiene & Tropical Medicine and Oxford University, leading pharmacoepidemiologists in the EU and Asia, as well as our outstanding publication record, including seven publications in The Lancet, and our initiatives at the EMA with ENCePP help us ensure the highest quality of our RWE studies.
OXON’s real-world experts ensure a customised approach via field, database or hybrid studies for safety, market access/HEOR and drug development.
We help support decision-making on the study design and provide critical inputs to determine the cost and time necessary to conduct observational research.
OXON counts on highly skilled professionals specialized in observational studies to ensure the highest quality data, on time and on budget.
OXON’s international Clinical Monitoring team has experience in a wide variety of therapeutic areas and works across the globe.
Post-marketing surveillance of drugs to discover effects that may present a risk. OXON provides different approaches to monitor the safety of licensed drugs.
We provide clients with a high-quality and cost-effective data management of single and multiple studies tailored to their project needs.
OXON provides advanced and appropriate statistical methods to analyse all study designs and data types across a wide range of therapeutic areas.
OXON provides pharmaceutical companies with a full range of services for scientific and marketing communications and regulatory submissions across diverse therapeutic areas.
We provide experienced medical writers to support in the medical writing of any clinical study, from regulatory documentation to scientific publications.
Looking for help with your Phase IV study?
Let our team lend you a hand.
As a CRO specialising in late-phase research and RWE, we offer customized strategies and tailored processes designed to meet highly specific needs. We provide a compendium of services to help clients worldwide generate real-world evidence of product effectiveness, safety, and value to assist healthcare decisions and enhance patient care.OUR SERVICES